title: Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes.
abstract: Human hepatocytes cultured serum-free for up to 6 weeks were used to study expression and induction of enzymes and membrane transport proteins involved in drug metabolism. Phase I drug metabolizing enzymes cytochrome P450 (CYP)1A1, CYP1A2, CYP2C9, CYP2C19, CYP2E1, and CYP3A4 were detected by Western blot analyses and, when appropriate, by enzymatic assays for ethoxyresorufin-O-deethylase(EROD)-activity and testosterone-6beta-hydroxylase(T6H)-activity. Expression of the membrane transporter multi-drug resistance protein (P-glycoprotein, MDR-1), multidrug resistance-associated protein (MRP-1), and lung-resistance protein (LRP) was maintained during the culture as detected by RT-PCR and Western blot analyses. Model inducers like rifampicin, phenobarbital, or 3-methylcholanthrene and beta-naphtoflavone were able to induce CYP1A or CYP3A4 as well as EROD or T6H activities for up to 30 days. CYP2C9, CYP2C19 and CYP2E1 expression was maintained but not inducible for 48 days. Also, rifampicin and phenobarbital were unable to increase MDR-1 and MRP-1 protein levels significantly.
authors.affiliation: Klinik für Innere Medizin I, Martin Luther Universität Halle-Wittenberg, Halle, 06097, Federal Republic of Germany.
authors.forename: D
authors.initials: D
authors.lastname: Runge
authors.forename: C
authors.initials: C
authors.lastname: Köhler
authors.forename: V E
authors.initials: VE
authors.lastname: Kostrubsky
authors.forename: D
authors.initials: D
authors.lastname: Jäger
authors.forename: T
authors.initials: T
authors.lastname: Lehmann
authors.forename: D M
authors.initials: DM
authors.lastname: Runge
authors.forename: U
authors.initials: U
authors.lastname: May
authors.forename: D B
authors.initials: DB
authors.lastname: Stolz
authors.forename: S C
authors.initials: SC
authors.lastname: Strom
authors.forename: W E
authors.initials: WE
authors.lastname: Fleig
authors.forename: G K
authors.initials: GK
authors.lastname: Michalopoulos
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000032:analysis / Q000235:genetics; D018528:ATP-Binding Cassette Transporters / Q000032:analysis / Q000235:genetics; D001189:Aryl Hydrocarbon Hydroxylases; D015153:Blotting, Western; D048429:Cell Size / Q000187:drug effects; D002478:Cells, Cultured; D019363:Cytochrome P-450 CYP1A1 / Q000096:biosynthesis / Q000378:metabolism; D019388:Cytochrome P-450 CYP1A2 / Q000096:biosynthesis / Q000378:metabolism; D065731:Cytochrome P-450 CYP2C19; D065729:Cytochrome P-450 CYP2C9; D019392:Cytochrome P-450 CYP2E1 / Q000378:metabolism; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000032:analysis* / Q000096:biosynthesis* / Q000378:metabolism; D004790:Enzyme Induction / Q000187:drug effects; D004815:Epidermal Growth Factor / Q000494:pharmacology; D017228:Hepatocyte Growth Factor / Q000494:pharmacology; D006801:Humans; D007527:Isoenzymes / Q000032:analysis / Q000096:biosynthesis; D008099:Liver / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology* / Q000648:ultrastructure; D008748:Methylcholanthrene / Q000494:pharmacology; D006899:Mixed Function Oxygenases / Q000096:biosynthesis / Q000378:metabolism; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D009363:Neoplasm Proteins / Q000235:genetics; D010634:Phenobarbital / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012293:Rifampin / Q000494:pharmacology; D039181:Steroid 16-alpha-Hydroxylase; D013250:Steroid Hydroxylases / Q000378:metabolism; D020394:Vault Ribonucleoprotein Particles / Q000235:genetics; D019324:beta-Naphthoflavone / Q000494:pharmacology; D000099187:Major Vault Protein
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D018528:ATP-Binding Cassette Transporters; D001189:Aryl Hydrocarbon Hydroxylases; D019363:Cytochrome P-450 CYP1A1; D019388:Cytochrome P-450 CYP1A2; D065731:Cytochrome P-450 CYP2C19; D065729:Cytochrome P-450 CYP2C9; D019392:Cytochrome P-450 CYP2E1; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System; D004815:Epidermal Growth Factor; D017228:Hepatocyte Growth Factor; D007527:Isoenzymes; D008748:Methylcholanthrene; D006899:Mixed Function Oxygenases; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D009363:Neoplasm Proteins; D010634:Phenobarbital; D012333:RNA, Messenger; D012293:Rifampin; D039181:Steroid 16-alpha-Hydroxylase; D013250:Steroid Hydroxylases; D020394:Vault Ribonucleoprotein Particles; D019324:beta-Naphthoflavone; D000099187:Major Vault Protein; C450260:CYP2C9 protein, human; C504573:CYP1A2 protein, human; C045793:CYP2C19 protein, human; C104464:CYP3A protein, human; C510163:CYP3A4 protein, human